Fig 1: mRNA levels of FN1 (A) and LAMA1 (B) were measured subject quantitative reverse transcriptase PCR in breast tumor and health breast tissues. Gene expression in breast tumor tissue treated with Magh-cit, Rh2(H2cit)4 and Magh-Rh2(H2cit)4 was compared with control (non-treated) and health group. The cDNA was prepared and 1.5 µg was used for each RT-PCR reaction. Three independent experiments were average. The values shown are the mean ± SEM of three independent experiments in triplicates, **p < 0.01 and ****p < 0.0001.
Fig 2: Quantification of Matrix Associated gene expression of Col1a2, Col3a1, Lox, Acta2, and Fn1. Gingival tissues were dissected from the rats to assess for gene expressions of (A) Col1a2, (B) Col3a1, (C) Lox, (D) and Acta2. Target gene expressions were normalized to 18 S using the ΔΔCt method. Data represents mean fold gene expressions ± s.d. relative to control day 0 of 6 independent animals run in triplicate. Data was analyzed via one-way ANOVA (*p < 0.05; **p < 0.01).
Fig 3: Forced expression of SPARC in Ishikawa cells induces EMT and cell migration. Successful lentiviral transduction of SPARC in Ishikawa cells was confirmed using immunoblotting (A), RT-qPCR (B) and ELISA (C). ACTB was used as an internal control (A). (D) The expression of FN1, VIM, CDH2 and CDH1 protein and mRNA in SPARC-expressing Ishikawa cells was analyzed using immunoblotting (D) and RT-qPCR (E). (F) In vitro cell migration was analyzed using transwell chamber assays. Images on the left show representative results. Graphs on the right show quantification data of the results. The scale bars indicate 100 μm. Ctrl, control; n.s., not significant; *, P < 0.05; **, P < 0.01. Full-length blot images are presented in Supplementary Fig. 2 and 3 (A, D). The experiments were independently repeated three times and representative data were shown
Fig 4: FN1 secreted from SPARC-expressing Ishikawa cells activates normal fibroblasts. (A) Amount of FN1 secreted from SPARC-expressing Ishikawa cells was measured by ELISA. (B) Protein levels of ACTA2 and CDH2 in NF cultured on FN1-coated dishes in the presence of recombinant SPARC were analyzed using immunoblotting. (C) NF were also analyzed for cell proliferation on day 6 in the same culture condition as (B). (D) NF cultured in the same condition as (B) were moved to collagen gel for in vitro contraction assays. (E) Successful knockdown of FN1 by siRNA (siFN1) was confirmed using ELISA. (F) Protein levels of ACTA2 and CDH2 in NF cultured in conditioned media from SPARC-expressing Ishikawa cells with siFN1 or immunodepleted of SPARC were analyzed using immunoblotting. NF were also analyzed for cell proliferation on day 6 (G) and in vitro contraction (H) in the conditioned media. (B, F) Intensity of the bands was quantified using Image J. Values of the protein-of-interest were corrected using the intensity of ACTB bands. Ctrl, control; rh SPARC, recombinant human SPARC; siCtrl, control siRNA; *, P < 0.05; **, P < 0.01. Full-length blot images are presented in Supplementary Fig. 10 and 11 (B, F). The experiments were independently repeated three times using identical fibroblasts and representative data were shown
Fig 5: Prevalent epithelial/mesenchymal hybrid state in epithelial cells during organogenesis. a Heatmap showing the representative epithelial and mesenchymal markers in epithelial and mesenchymal cells. The color key from blue to red indicates low to high gene expression, respectively. b Immunostaining of Cdh1, Vim, and Fn1 in E11.5 intestine, liver, and lung. The white arrow indicates potential co-expression of Cdh1 and Vim. c Immunostaining for Epcam and Vim in adult intestine and lung
Supplier Page from Abcam for Anti-Fibronectin antibody - BSA and Azide free